Answers are grounded in this paper and cite their sources.
Findings reveal associations of sex, race, and ancestry with amyloid pathology, suggesting implications for Alzheimer disease risk assessment.
The findings indicate that female sex, APOEε4, and both race and African ancestry were jointly associated with amyloid in this study population. Excess amyloid among women may partly explain their greater tau burden and steeper cognitive decline. These findings highlight the importance of incorporating sex, race, and ancestry into biomarker thresholds, risk stratification, and the design of preventive or disease-modifying trials for Alzheimer disease.
No takes yet. Share an insight, caveat, or question.
Raya et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: